SUANFARMA announces its participation in the Child Vaccination Alliance, an initiative established 15 years ago by the “la Caixa” Foundation in collaboration with Gavi, the Vaccine Alliance, and with the scientific and academic support of ISGlobal. This alliance aims to provide Spanish companies with the opportunity to collaborate on a cooperative project to combat child mortality in developing countries with limited access to universal healthcare.Continue reading
SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products
SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. This bilateral agreement between the Spanish multinational, providing the technology internally developed and its partner Reyoung with a well-known trustability in manufacturing capabilities, will constitute a strategic cooperation for anti-infective and antibacterial API production. These drugs are crucial to guaranteeing the health of the population. Both companies consider it essential to ensure the supply of this therapeutic line, especially in these times of shortages and increased supply chain uncertainty for the global pharma industry.Continue reading
Collaboration with Willow on development of large volume anti-infective api through precision fermentation
Willow Biosciences and SUANFARMA jointly announced execution of a collaboration agreement for a cell line productivity optimization development program for manufacturing a large volume anti-infective Active Pharmaceutical Ingredient (“API”) through precision fermentation. Through the partnership, SUANFARMA will have access to Willow’s proprietary strain optimization technologies to develop a more cost-effective production process.
This innovative solution for the wastewater treatment plant is based on electro-oxidation, which does not require the use of dangerous chemicals and can remove non-biodegradable compounds and pollutants from industrial volumes of wastewater, making it a much more efficient and eco-friendly option compared to existing technologies.
We are pleased to announce that the groundbreaking Pharmaceutical Wastewater Treatment Project led by SUANFARMA and e-Watts Partner has been nominated for the 2023 CPHI Awards in the Sustainability category.
This innovative solution for the wastewater treatment plant is based on electro-oxidation, which does not require the use of dangerous chemicals and can remove non-biodegradable compounds and pollutants from industrial volumes of wastewater, making it a much more efficient and eco-friendly option compared to existing technologies.Continue reading
We pride ourselves on implementing an all-around Good Manufacturing Practices (GMP) culture. Our commitment to quality is valued and acknowledged by our clients, evident through successful external audits and inspections. We consistently deliver on our promise of maintaining a robust quality system that instills trust and confidence in our customers. Our unwavering dedication to quality sets us apart, making SUANFARMA CDMO the preferred choice for those seeking excellence in their partnerships.
In conclusion, the Quality Department of SUANFARMA CDMO operates with a relentless pursuit of quality, adapting to challenges, and building strong relationships with our customers.Continue reading
Quality Assurance and Quality Control in the Pharmaceutical Industry: Driving Excellence and Safety of Medicines
In the pharmaceutical industry, quality and safety are fundamental aspects that cannot be compromised at any time. To achieve this, two teams play a crucial role: the Quality Assurance Team and the Quality Control Team.Continue reading
At SUANFARMA we are committed to actively contributing to the protection of the environment and to being agents of change towards a more sustainable future.Continue reading
Lymecycline is a Powerful Antibiotic for Fighting Bacterial Infections. Lymecycline is used in the treatment of moderate to severe acne. Its high activity against Propionibacterium acnes makes it a powerful tool in fighting acne outbreaks.Continue reading
At SUANFARMA CDMO, we pride ourselves on our chemical synthesis capabilities within the Industrial Division. Our factories are equipped to handle chemical synthesis processes on both pilot and industrial scales. With a focus on innovation and efficiency, we have developed an integrated technological platform that allows us to develop, familiarize, scale up, and validate chemical processes seamlessly.Continue reading
At SUANFARMA we work to improve industrial processes and reduce the use of certain raw materials in pursuit of more sustainable production.Continue reading